Home Nerio Therapeutics

Nerio Therapeutics

acquired
-
Immuno-oncology Researcher

Basic Information

Nerio Therapeutics is a biopharmaceutical company operator focused on licensing phosphatase drug discovery for immunotherapy. The company provides novel phosphatase modulators, leveraging deep expertise in protein phosphatases, high-throughput screening technologies, and structure-guided chemical approaches to deliver selective, cell-permeable, bioavailable, and potent small-molecule phosphatase modulators for immuno-oncology applications.
Nerio Therapeutics, Inc.
California,United States of America
15~50 people
January 01, 2019
--